Identification of relevant peptides involved in the initiation and progression of autoimmune diabetes
鉴定参与自身免疫性糖尿病发生和进展的相关肽
基本信息
- 批准号:9689765
- 负责人:
- 金额:$ 40.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAntigensAutoimmune DiabetesAutoimmune ProcessBeta CellBindingBiochemicalBiological AssayBloodCD4 Positive T LymphocytesCellsCellular biologyCytoplasmic GranulesDendritic CellsDevelopmentDiabetes MellitusDiseaseEndocrinologistEvaluationGlucoseGoalsHumanHybridomasImmunologicsImmunologistIn VitroInbred NOD MiceIndividualInsulinInsulin-Dependent Diabetes MellitusInvestigationIslets of LangerhansLeadLymphoidLymphoid TissueMass Spectrum AnalysisMeasuresMouse StrainsMusNon obeseOrganPathogenesisPeptidesPeripheralPhagocytesPopulationPrediabetes syndromeProcessProteinsReactionSamplingSeminalSiteSourceSpleenT-LymphocyteTechniquesTechnologyTestingThymus GlandTissuesUrineValidationVesicleautoreactivitydiabeticdiabetogenicexperienceexperimental studygranule cellimmunogenicin vivoinstrumentationisletlymph nodesmacrophagenon-diabeticnovelresponse
项目摘要
Project Summary
We propose a collaborative project involving immunologists experienced in autoimmune
diabetes, mass-spectrometrists, and endocrinologists-diabetologists. Our combined efforts are
to specifically identify relevant peptides from beta cell proteins involved in the
immunopathogenesis of type 1 diabetes. The project combines experimental studies in
diabetes-prone mice that should lead to targeted evaluation of human samples. The ultimate
goal is to identify peptides that form the substrate for the autoreactive MHC-II response that
initiates and perpetuates the process. Important is to identify relevant diabetogenic antigens at
different stages of the autoimmune reaction from pre-diabetes to the initial progression: it will
include their characterization, source in beta cells, involvement in the disease process, and sites
of presentation.
Aim 1 consists of an identification of novel peptides derived from beta cell granules of
both mice and humans. We examine vesicles isolated from beta cells with a major focus on
crinosomes. Crinosomes and insulin dense core granules will be isolated during different stages
of diabetes development, their peptides will be isolated and examined by sophisticated mass
spectrometry with state of the art instrumentation and technology. We will place emphasis in
unique structural or post translational changes in peptides and whether the panoply of them
changes as the beta cell progresses into active diabetes. We also will examine vesicles and
exocytosed products from human islets from recently diseased individuals.
Aim 2 will be an immunological validation of novel peptides identified by mass
spectrometry. Immunological and biochemical assays will be used to validate the ability of beta
cell derived peptides to bind to I-Ag7 and activate T cells in vitro and in vivo.
Aim 3 will be the Identification and validation of the MHC-II-bound peptidome in islets and
secondary lymphoid organs. We plan to examine the peptidome eluted from MHC-II
molecules expressed by phagocytes obtained from islets, peripheral lymph nodes, and spleens
of the NOD mouse and to characterize/validate them as in Aims 1/2. This is the seminal test to
prove an immunogenic peptide, that is, it's a positive identification bound in vivo to MHC-II
alleles.
项目摘要
我们提出了一个合作项目,涉及有经验的免疫学家在自身免疫性
糖尿病专家、质谱专家和内分泌专家-糖尿病专家。我们的共同努力
为了特异性地鉴定来自β细胞蛋白的相关肽,
1型糖尿病的免疫发病机制。该项目结合了实验研究,
糖尿病易感小鼠,这应该导致有针对性的评估人类样本。最终
目的是鉴定形成自身反应性MHC-II应答底物的肽,
启动并延续这一过程。重要的是要确定相关的致糖尿病抗原,
从糖尿病前期到初始进展的自身免疫反应的不同阶段:它将
包括其特征、β细胞来源、参与疾病过程和部位
的介绍。
目的1包括鉴定来源于人的β细胞颗粒的新肽,
老鼠和人类都是。我们研究了从β细胞分离的囊泡,主要关注
毛体在不同的阶段,将分离出核小体和胰岛素致密核心颗粒
糖尿病的发展,他们的肽将被分离和检查复杂的质量
使用最先进的仪器和技术进行光谱分析。我们将重点放在
肽中独特的结构或翻译后变化,以及它们是否
随着β细胞进展为活动性糖尿病而发生变化。我们还将检查囊泡,
来自最近患病个体的人胰岛的胞吐产物。
目标2将是通过质量鉴定的新肽的免疫学验证
光谱法免疫学和生物化学测定将用于验证β
细胞衍生肽结合I-Ag 7并在体外和体内活化T细胞。
目标3将是在胰岛中鉴定和验证MHC-II结合肽组,
次级淋巴器官我们计划检测从MHC-II洗脱的肽组
从胰岛、外周淋巴结和脾脏获得的吞噬细胞表达的分子
NOD小鼠,并按照目标1/2对其进行表征/验证。这是一个开创性的测试,
证明一种免疫原性肽,也就是说,它在体内与MHC-II结合是阳性鉴定
等位基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMIL Raphael UNANUE其他文献
EMIL Raphael UNANUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMIL Raphael UNANUE', 18)}}的其他基金
Identification of relevant peptides involved in the initiation and progression of autoimmune diabetes
鉴定参与自身免疫性糖尿病发生和进展的相关肽
- 批准号:
10246429 - 财政年份:2018
- 资助金额:
$ 40.47万 - 项目类别:
AUTOIMMUNE DIABETES: EARLY EVENTS IN ISLETS OF LANGERHANS
自身免疫性糖尿病:朗格汉斯岛的早期事件
- 批准号:
9197630 - 财政年份:2015
- 资助金额:
$ 40.47万 - 项目类别:
CHARACTERIZATION OF ANTIGENIC PEPTIDES PRESENTED BY I-AG7
I-AG7 呈现的抗原肽的表征
- 批准号:
8361393 - 财政年份:2011
- 资助金额:
$ 40.47万 - 项目类别:
IDENTIFICATION OF MODIFIED AND NATURAL HEL PEPTIDE FRAGMENTS PRESENTED BY MHC
MHC 呈现的修饰和天然 HEL 肽片段的鉴定
- 批准号:
8361330 - 财政年份:2011
- 资助金额:
$ 40.47万 - 项目类别:
IDENTIFICATION OF MODIFIED AND NATURAL HEL PEPTIDE FRAGMENTS PRESENTED BY MHC
MHC 呈现的修饰和天然 HEL 肽片段的鉴定
- 批准号:
8168678 - 财政年份:2010
- 资助金额:
$ 40.47万 - 项目类别:
PEPTIDES IDENTIFIED FROM THE TYPE I DIABETES ASSOCIATED MHC CLASS I-H2-KD
从 I 型糖尿病相关 MHC I-H2-KD 类中鉴定出的肽
- 批准号:
8168690 - 财政年份:2010
- 资助金额:
$ 40.47万 - 项目类别:
CHARACTERIZATION OF ANTIGENIC PEPTIDES PRESENTED BY I-AG7
I-AG7 呈现的抗原肽的表征
- 批准号:
8168793 - 财政年份:2010
- 资助金额:
$ 40.47万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 40.47万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别: